International Conferences

Recommended Conferences for Decongestant medicine

Decongestant medicine

---

Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums so far in the field.

Decongestants are a type of medicine that can provide short-term relief for a blocked nose. Decongestants reduce swelling of the blood vessels inside your nose. This helps to open up your nasal airway, making breathing easier. Nasal decongestants help relieve nasal congestion by narrowing (constricting) the blood vessels and reducing blood flow and swelling, allowing you to breathe more easily. Pseudoephedrine, Neo-Synephrine, Nexafed, Phenylpropanolamine, Empro, Lusonal liquid, nasofed, Propagest, Sudodrin, Unifed liquid and Westrim are decongestant medicine that acts by stimulating the alpha-adrenergic receptors. In US, the number of adults with diagnosed sinusitis is 28.5 million and about 12.1%percent of adults with diagnosed sinusitis. Decongestants are a type of medicine that can provide short-term relief for a blocked nose (nasal congestion).

OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that ConferenceSeries hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker.

They can be taken to ease the symptoms of congestion when you have:

•     a common cold

•     hay fever, or other allergic reactions, such as to dust mites

•     the flu

•    sinusitis

Many decongestants can be bought over the counter in pharmacies without a prescription. They are available as tablets or a nasal spray.

Decongestants are sympathomimetic drugs that act by stimulating the alpha-adrenergic receptors. Decongestants are either taken orally or applied locally in the form of nasal sprays or drops. The decongestant effect is due to vasoconstriction of the blood vessels in the nose, sinuses, etc. The vasoconstriction effect reduces swelling or inflammation and mucus formation in the nasal passage and makes it easier to breath.

Drug Name:

•             Drixoral Decongestant Non-Drowsy

•             Sudafed 12-Hour

•             AH-Chew D

•             Contac-D

•             Contac Cold

•             ElixSure Congestion

Decongestants are not usually recommended for children aged under 12, for women who are breastfeeding and for people with certain health conditions, such as high blood pressure.It is not recommended to use decongestants for more than seven days, as they can cause your nose to become more blocked once you stop taking them. When side effects occur after taking decongestants, they tend to be mild. These can include:

•             Dry mouth

•             Headache

•             Feeling sick

Decongestants reduce swelling of the blood vessels inside your nose. This helps to open up your nasal airway, making breathing easier. However, although decongestants can help you to breathe more easily, they cannot cure the underlying cause of your blocked nose, such as a cold or allergy

List of Best International Conferences

2^nd   Brain Disorders Conference, October 27-29, 2016 Chicago, USA.

5^th Neurology Conference, March 14-16, 2016 London, UK.

2^nd Neurological Disorders and Stroke Conference April 28-30, 2016 Dubai, UAE

2^nd Parkinson’s Disease and Movement Disorders Conference November 28-30, 2016 Chicago, USA

6^th Neurological Conference May 19-21, 2016 San Antonio, USA

Eating Disorders Congress August 15-17, 2016 Portland, Oregon

4^th Vascular Dementia Conference June 30-July 2, 2016 Valencia, Spain

5^th Alzheimer’s Disease and Dementia Conference September 29-Oct 1, 2016 London, UK

2^nd Sleep Disorders Conference November 28- 30, 2016 Chicago, USA

2^nd Epilepsy Conference October 24-26, 2016 Rome, Italy

Autism Conference, May 5-6, 2016 Chicago, USA

Annual Drug & Medical Device Litigati2015

20th Annual Drug & Medical Device Litigation, December 2-4, 2015, NY, United States.

Nasal Drug Delivery Annual Conference, April 16-17, 2015, London.

Clinical Drug Development and Approval Process , October 8-9, 2015, San Diego, CA, United States.

2nd International Conference and Exhibition on Rhinology & Otology

29th International Papillomavirus Conference and Clinical & Public Health Workshops

Karen Zupko Otolaryngology Coding and Reimbursement Workshops

The Osler Institute Otolaryngology Lecture Review

Update in Pediatric Airway, Voice and Swallowing Disorders

15th British Academic Conference in Otolaryngology (BACO)

American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNSF) Annual Meeting

List of Related Societies:

American Rhinologic Society (ARS)

American Academy of Otolaryngology

World Health Organization

Medical University of South Carolina Sinus Center

The Sinus and Allergy Center of Northwestern University

Combined Otolaryngology Spring Meetings (COSM)

National Institutes of Health

MEDSCAPE

List of Related Companies

Theon Pharmaceuticals Private Limited, India

MedlinePlus

Panex

PCD Pharma Company

ROWAN Bioceuticalspvt.ltd

Cygnus Healthcare Specialities Private Limited

Mc Neil Products Ltd

Urumqi dinghua co.ltd

The nasal devices market has been forecast to increase at a compound annual growth rate (CAGR) of 7.37% through to 2016, driven by advancements in the cochlear implant devices segment and an increase in the number of acquisitions and new entrants. According a recent statistical survey, the proportion of people suffering from the disease is expected to increase by 66.7% in future. Institutions performing research in the related studies have been funded with 225 Million Dollar worldwide. According to recent statistics, nasal diseases worldwide will double between 2012 and 2030. The current market value of Otolaryngology is $190 billion and is expected to reach more than $500 billion by 2020.

Decongestants are a type of medicine that can provide short-term relief for a blocked nose (nasal congestion). 

This page will be updated regularly.

This page was last updated on July 4, 2024